Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue ...

Charles River Laboratories on Wednesday raised its annual profit forecast, betting on growing demand for its drug discovery and development services from drugmakers, sending its shares up more than 4% ...

Charles River Laboratories' annual profit forecast raise on Wednesday was clouded by investor concerns about the higher number of order cancellations from clients, sending the contract research firm's ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

Second-Quarter GAAP Earnings per Share of $1.06 and Non-GAAP Earnings per Share of $3.12 – – Updates 2025 Guidance – WILM ...

Investing.com -- Charles River Laboratories International, Inc. (NYSE: CRL) shares jumped 6.9% after the company reported second-quarter earnings on Wednesday that significantly exceeded analyst ...

The FDA greenlit multiple new drugs this month and issued some notable label expansions, including for Eli Lilly’s Kisunla.

Delhi High Court rules cyberbullying can be as traumatic as physical assault, upholding conviction in a case involving a minor victim and morphed ...

The Supreme Court on Monday (August 4) asked former Chhattisgarh Chief Minister Bhupesh Baghel and his son Chaitanya Baghel ...

Famous for its wild, labyrinth-like interior and a parade of long-gone stores and restaurants, the building once called Metro ...

A Relative Strength Rating upgrade for Caris Life Sciences shows improving technical performance. Will it continue?